Published • loading... • Updated
WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year
WuXi Biologics achieved a Top 1% score in the 2025 Corporate Sustainability Assessment, earning global recognition for the fourth year amid strong ESG commitments and awards.
- On March 2, 2026, WuXi Biologics announced its inclusion in the S&P Global Sustainability Yearbook 2026 and a top industry ranking with a Top 1% CSA Score for the fourth year.
- In a competitive review of more than 9,200 firms, S&P Global's Yearbook 2026 selected 848 companies based on the 2025 CSA, highlighting top performers across 59 industries.
- WuXi Biologics operates facilities that use next-generation biomanufacturing technologies and supports 945 client projects, including 74 in Phase III and 25 in commercial manufacturing, as of December 31, 2025.
- WuXi's inclusion in the Yearbook and high CSA performance reinforce its ESG leadership and support its broad global capacity, supported by participation in multiple sustainability initiatives.
- Beyond Yearbook inclusion, WuXi participates in the UNGC and PSCI, and holds external recognitions including MSCI , EcoVadis , DJSI listing, and CDP .
Insights by Ground AI
27 Articles
27 Articles
+26 Reposted by 26 other sources
WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year
SHANGHAI, March 1, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been included in the S&P Global Sustainability Yearbook 2026 ("Yearbook") in recognition of its strong performance in the…
Coverage Details
Total News Sources27
Leaning Left4Leaning Right3Center8Last UpdatedBias Distribution53% Center
Bias Distribution
- 53% of the sources are Center
53% Center
L 27%
C 53%
R 20%
Factuality
To view factuality data please Upgrade to Premium














